Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	948.34	885.30	84.45
Graham Fair Price	-66.82	1.54	4.63
PEG	186.69	1.31	0.46
Price/Book	-7.96	2.31	2.51
Price/Cash Flow	-55.45	-5.96	13.37
Prices/Earnings	729.87	-146.27	17.63
Price/Sales	523.28	19.64	3.15
Price/FCF	-55.45	-5.96	13.37
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-37.62	0.07	0.10
Operating Margin	-71.24	0.03	0.09
ROA	-88.04	< 0.005	< 0.005
ROE	0.04	< 0.005	-88.91
ROIC	0.02	< 0.005	-91.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	0.09	-24.76
Dividends QOQ	-0.57	0.18	-68.02
EBIT QOQ	1.08	-0.96	-11.11
EPS QOQ	0.38	-1.11	189.47
FCF QOQ	1.91	-3.06	60.37
Revenue QOQ	-0.10	-0.85	-712.94
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	5.49	40.53	638.06
Days Sales Outstanding (DSO)	195.07	1294.50	563.61
Inventory Turnover	16.39	2.22	-86.45
Debt/Capitalization	0.67	0.69	2.15
Quick Ratio	1.06	1.11	4.56
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.17	5.15	-0.38
Cash	5.80	4.11	-29.10
Capex	< 0.005	< 0.005	-14.02
Free Cash Flow	0.97	-2.00	105.80
Revenue	4.13	0.61	-85.29
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.16	1.20	2.88
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	21.51	331.71	1441.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating